Publications for Vlado Perkovic
Publications for Vlado Perkovic
2016
Gallagher, M., Wong, M., Perkovic, V. (2016).
ALTITUDE: defining a ceiling for blockade of
the renin-angiotensin system? The Lancet
Diabetes & Endocrinology, 4(4), 289-290. <a
href="http://dx.doi.org/10.1016/
S2213-8587(15)00415-5">[More
Information]</a>
Wang, Y., Ivany, J., Perkovic, V., Gallagher, M.,
Woodward, M., Jardine, M. (2016).
Anticoagulants and antiplatelet agents for
preventing central venous haemodialysis catheter
malfunction in patients with end-stage kidney
disease. Cochrane Database of Systematic
Reviews, 2016 (4), 1-82. <a
href="http://dx.doi.org/10.1002/14651858.CD00
9631.pub2">[More Information]</a>
Xie, X., Atkins, E., Lv, J., Bennett, A., Neal, B.,
Ninomiya, T., Woodward, M., MacMahon, S.,
Turnbull, F., Hillis, G., Chalmers, J., Salam, A.,
Perkovic, V., Rodgers, A., et al (2016). Effects
of intensive blood pressure lowering on
cardiovascular and renal outcomes: updated
systematic review and meta-analysis. The
Lancet, 387(10017), 435-443. <a
href="http://dx.doi.org/10.1016/S0140-6736(15)
00805-3">[More Information]</a>
Wu, J., Foote, C., Blomster, J., Toyama, T.,
Perkovic, V., Sundstrom, J., Neal, B. (2016).
Effects of sodium-glucose cotransporter-2
inhibitors on cardiovascular events, death, and
major safety outcomes in adults with type 2
diabetes: a systematic review and meta-analysis.
The Lancet Diabetes & Endocrinology, 4(5),
411-419. <a
href="http://dx.doi.org/10.1016/S2213-8587(16)
00052-8">[More Information]</a>
Fulcher, G., Matthews, D., Perkovic, V., de
Zeeuw, D., Mahaffey, K., Mathieu, C., Woo, V.,
Wysham, C., Capuano, G., Desai, M., Neal, B.,
et al (2016). Efficacy and safety of canagliflozin
when used in conjunction with incretin-mimetic
therapy in patients with type 2 diabetes.
Diabetes, Obesity and Metabolism, 18(1), 82-91.
<a
href="http://dx.doi.org/10.1111/dom.12589">[M
ore Information]</a>
Dal-Re, R., Jha, V., Lv, J., Chaudhury, R.,
Wang, Y., Perkovic, V. (2016). International
trials in middle-income countries: different local
scenarios require different ethical approaches.
Journal of the Royal Society of Medicine, 109(2),
47-51. <a
href="http://dx.doi.org/10.1177/0141076815608
854">[More Information]</a>
Nigwekar, S., Kang, A., Zoungas, S., Cass, A.,
Gallagher, M., Kulshrestha, S., Navaneethan, S.,
Perkovic, V., Strippoli, G., Jardine, M. (2016).
Interventions for lowering plasma homocysteine
levels in dialysis patients. Cochrane Database of
Systematic Reviews, 2016 (5), 1-47. <a
href="http://dx.doi.org/10.1002/14651858.CD00
4683.pub4">[More Information]</a>
Wong, M., Perkovic, V., Chalmers, J.,
Woodward, M., Li, Q., Cooper, M., Hamet, P.,
Harrap, S., Heller, S., MacMahon, S., Neal, B.,
Rodgers, A., Zoungas, S., et al (2016).
Long-term Benefits of Intensive Glucose Control
for Preventing End-Stage Kidney Disease:
ADVANCE-ON. Diabetes Care, 39(5), 694-700.
<a
href="http://dx.doi.org/10.2337/dc15-2322">[M
ore Information]</a>
Schievink, B., de Zeeuw, D., Smink, P., Andress,
D., Brennan, J., Coll, B., Correa-Rotter, R., Hou,
F., Kohan, D., Perkovic, V., et al (2016).
Prediction of the effect of atrasentan on renal and
heart failure outcomes based on short-term
changes in multiple risk markers. European
Journal of Preventive Cardiology, 23(7),
758-768. <a
href="http://dx.doi.org/10.1177/2047487315598
709">[More Information]</a>
Xie, X., Liu, Y., Perkovic, V., Li, X., Ninomiya,
T., Hou, W., Zhao, N., Liu, L., Lv, J., Zhang, H.,
et al (2016). Renin-Angiotensin System
Inhibitors and Kidney and Cardiovascular
Outcomes in Patients with CKD: A Bayesian
Network Meta-analysis of Randomized Clinical
Trials. American Journal of Kidney Diseases,
67(5), 728-741. <a
href="http://dx.doi.org/10.1053/j.ajkd.2015.10.0
11">[More Information]</a>
Knight, J., Perkovic, V. (2016). The Affordable
Dialysis Prize steams ahead. The Lancet,
387(10023), 1040-1040. <a
href="http://dx.doi.org/10.1016/S0140-6736(16)
00657-7">[More Information]</a>
2015
Johnson, D., Pascoe, E., Badve, S., Dalziel, K.,
Cass, A., Clarke, P., Ferrari, P., McDonald, S.,
Morrish, A., Pedagogos, E., Perkovic, V., et al
(2015). A Randomized, Placebo-Controlled Trial
of Pentoxifylline on Erythropoiesis-Stimulating
Agent Hyporesponsiveness in Anemic Patients
With CKD: The Handling Erythropoietin
Resistance With Oxpentifylline (HERO) Trial.
American Journal of Kidney Diseases, 65(1),
49-57. <a
href="http://dx.doi.org/10.1053/j.ajkd.2014.06.0
20">[More Information]</a>
Jun, M., Turin, T., Woodward, M., Perkovic, V.,
Lambers Heerspink, H., Manns, B., Tonelli, M.,
Hemmelgarn, B. (2015). Assessing the Validity
Publications for Vlado Perkovic
of Surrogate Outcomes for ESRD: A
Meta-Analysis. Journal of the American Society
of Nephrology, 26(9), 2289-2302. <a
href="http://dx.doi.org/10.1681/ASN.201404039
6">[More Information]</a>
Badve, S., Zhang, L., Coombes, J., Pascoe, E.,
Cass, A., Clarke, P., Ferrari, P., McDonald, S.,
Morrish, A., Pedagogos, E., Perkovic, V., et al
(2015). Association between serum alkaline
phosphatase and primary resistance to
erythropoiesis stimulating agents in chronic
kidney disease: a secondary analysis of the
HERO trial. Canadian journal of kidney health
and disease, 2, 1-10. <a
href="http://dx.doi.org/10.1186/s40697-015-006
6-5">[More Information]</a>
Emdin, C., Rahimi, K., Neal, B., Callender, T.,
Perkovic, V., Patel, A. (2015). Blood Pressure
Lowering in Type 2 Diabetes: A Systematic
Review and Meta-analysis. JAMA: The Journal
of the American Medical Association, 313(6),
603-615. <a
href="http://dx.doi.org/10.1001/jama.2014.18574
">[More Information]</a>
Zhu, B., Zhu, C., Lin, Y., Perkovic, V., Li, X.,
Yang, R., Tang, X., Zhu, X., Cheng, X., Li, Q.,
et al (2015). Clinical characteristics of IgA
nephropathy associated with low complement 4
levels. Renal Failure, 37(3), 424-432. <a
href="http://dx.doi.org/10.3109/0886022X.2014.
994408">[More Information]</a>
Laba, T., Usherwood, T., Leeder, S., Yusuf, F.,
Gillespie, J., Perkovic, V., Wilson, A., Jan, S.,
Essue, B. (2015). Co-payments for health care:
what is their real cost? Australian Health Review,
39(1), 33-36. <a
href="http://dx.doi.org/10.1071/AH14087">[Mo
re Information]</a>
Jardine, M., Zuo, L., Gray, N., de Zoysa, J.,
Chan, C., Gallagher, M., Howard, K., Heritier,
S., Cass, A., Perkovic, V. (2015). Design and
participant baseline characteristics of 'A Clinical
Trial of IntensiVE Dialysis' - the ACTIVE
Dialysis Study. Nephrology, 20(4), 257-265. <a
href="http://dx.doi.org/10.1111/nep.12385">[Mo
re Information]</a>
Groop, P., Cooper, M., Perkovic, V., Sharma, K.,
Schernthaner, G., Haneda, M., Hocher, B.,
Gordat, M., Cescutti, J., et al (2015). Dipeptidyl
peptidase-4 inhibition with linagliptin and effects
on hyperglycaemia and albuminuria in patients
with type 2 diabetes and renal dysfunction:
Rationale
and design of the MARLINA–T2D™ trial.
Diabetes and Vascular Disease Research, 12(6),
455-462. <a
href="http://dx.doi.org/10.1177/1479164115579
002">[More Information]</a>
Ying, A., Arima, H., Czernichow, S., Woodward,
M., Huxley, R., Turnbull, F., Perkovic, V., Neal,
B. (2015). Effects of blood pressure lowering on
cardiovascular risk according to baseline
body-mass index: a meta-analysis of randomised
trials. The Lancet, 385(9971), 867-874. <a
href="http://dx.doi.org/10.1016/S0140-6736(14)
61171-5">[More Information]</a>
Fulcher, G., Matthews, D., Perkovic, V., de
Zeeuw, D., Mahaffey, K., Weiss, R., Rosenstock,
J., Capuano, G., Desai, M., Shaw, W., Neal, B.,
et al (2015). Efficacy and Safety of Canagliflozin
Used in Conjunction with Sulfonylurea in
Patients with Type 2 Diabetes Mellitus: A
Randomized, Controlled Trial. Diabetes
Therapy, 6(3), 289-302. <a
href="http://dx.doi.org/10.1007/s13300-015-011
7-z">[More Information]</a>
Neal, B., Perkovic, V., de Zeeuw, D., Mahaffey,
K., Fulcher, G., Ways, K., Desai, M., Shaw, W.,
Capuano, G., Alba, M., et al (2015). Efficacy and
Safety of Canagliflozin, an Inhibitor of Sodium
Glucose Cotransporter 2, When Used in
Conjunction With Insulin Therapy in Patients
With Type 2 Diabetes. Diabetes Care, 38(3),
403-411. <a
href="http://dx.doi.org/10.2337/dc14-1237">[M
ore Information]</a>
Jun, M., Perkovic, V. (2015). Fibrates:
Risk-Benefits and Role in Treating
Dyslipidemias. In Abhimanyu Garg (Eds.),
Dyslipidemias: Pathophysiology, Evaluation and
Management, (pp. 423-438). Totowa: Humana
Press. <a
href="http://dx.doi.org/10.1007/978-1-60761-42
4-1_25">[More Information]</a>
Jardine, M., Perkovic, V. (2015). First Light after
the Long Night: A Follow-up Report of the
Randomized FHN Nocturnal Trial. American
Journal of Kidney Diseases, 66(3), 379-382. <a
href="http://dx.doi.org/10.1053/j.ajkd.2015.06.0
07">[More Information]</a>
Palmer, S., Navaneethan, S., Craig, J., Johnson,
D., Perkovic, V., Hegbrant, J., Strippoli, G.
(2015). HMG CoA reductase inhibitors (statins)
for people with chronic kidney disease not
requiring dialysis. Sao Paulo medical journal,
133(6), 541-542. <a
href="http://dx.doi.org/10.1590/1516-3180.2015
1336T2">[More Information]</a>
Lo, C., Toyama, T., Hirakawa, Y., Jun, M., Cass,
A., Hawley, C., Badve, S., Perkovic, V.,
Zoungas, S., Pilmore, H. (2015). Insulin and
glucose-lowering agents for treating people with
diabetes and chronic kidney disease. Cochrane
Database of Systematic Reviews, (8), 1-15. <a
href="http://dx.doi.org/10.1002/14651858.CD01
1798">[More Information]</a>
Publications for Vlado Perkovic
Kang, A., Nigwekar, S., Perkovic, V.,
Kulshrestha, S., Zoungas, S., Navaneethan, S.,
Cass, A., Gallagher, M., Ninomiya, T., Strippoli,
G., Jardine, M. (2015). Interventions for
lowering plasma homocysteine levels in
kidney transplant recipients. Cochrane Database
of Systematic Reviews, 5, 1-27. <a
href="http://dx.doi.org/10.1002/14651858.CD00
7910.pub2">[More Information]</a>
Verhoeven, A., Cottrill, A., Schmiede, A.,
Brown, A., Scott, A., Morton, B., Ross, B.,
Dalton, C., Cook, D., Peiris, D., Salkeld, G.,
Hickie, I., Gillespie, J., Jan, S., Usherwood, T.,
Laba, T., Perkovic, V., et al (2015). Investing in
healthier lives: Pathways to healthcare financing
reform in Australia, A Health Policy Report August 2015, (pp. 2 - 15). Sydney, Australia:
George Institute for Global Health.
Cooper, M., Perkovic, V., McGill, J., Groop, P.,
Wanner, C., Rosenstock, J., Hehnke, U., Woerle,
H., von Eynatten, M. (2015). Kidney Disease
End Points in a Pooled Analysis of Individual
Patient-Level Data From a Large Clinical Trials
Program of the Dipeptidyl Peptidase 4 Inhibitor
Linagliptin in Type 2 Diabetes. American
Journal of Kidney Diseases, 66(3), 441-449. <a
href="http://dx.doi.org/10.1053/j.ajkd.2015.03.0
24">[More Information]</a>
Wong, M., Wanner, C., Knight, J., Perkovic, V.
(2015). Lowering cholesterol in chronic kidney
disease: is it safe and effective? European Heart
Journal, 36(43), 2988-2995. <a
href="http://dx.doi.org/10.1093/eurheartj/ehv393
">[More Information]</a>
Kohan, D., Heerspink, H., Coll, B., Andress, D.,
Brennan, J., Kitzman, D., Correa-Rotter, R.,
Makino, H., Perkovic, V., Hou, F., et al (2015).
Predictors of Atrasentan-Associated Fluid
Retention and Change in Albuminuria in Patients
with Diabetic Nephropathy. Clinical Journal of
the American Society of Nephrology, 10(9),
1568-1574. <a
href="http://dx.doi.org/10.2215/CJN.00570115"
>[More Information]</a>
Perkovic, V., Rodgers, A. (2015). Redefining
blood-pressure targets - SPRINT starts the
marathon. New England Journal of Medicine,
373(22), 2175-2178. <a
href="http://dx.doi.org/10.1056/NEJMe1513301
">[More Information]</a>
Toyama, T., Furuichi, K., Shimizu, M., Akinori,
H., Iwata, Y., Sakai, N., Perkovic, V.,
Kobayashi, M., Mano, T., Kaneko, S., et al
(2015). Relationship between Serum Uric Acid
Levels and Chronic Kidney Disease in a
Japanese Cohort with Normal or Mildly Reduced
Kidney Function. PloS One, 10(9), 1-11. <a
href="http://dx.doi.org/10.1371/journal.pone.013
7449">[More Information]</a>
Perkovic, V., Jardine, M., Vijapurkar, U.,
Meininger, G. (2015). Renal effects of
canagliflozin in type 2 diabetes mellitus. Current
Medical Research and Opinion, 31(12),
2219-2231. <a
href="http://dx.doi.org/10.1185/03007995.2015.
1092128">[More Information]</a>
Tong, A., Crowe, S., Chando, S., Cass, A.,
Chadban, S., Chapman, J., Gallagher, M.,
Hawley, C., Hill, S., Howard, K., Perkovic, V.,
Pollock, C., Strippoli, G., Webster, A., Wong,
G., Craig, J., et al (2015). Research Priorities in
CKD: Report of a National Workshop Conducted
in Australia. American Journal of Kidney
Diseases, 66(2), 212-222. <a
href="http://dx.doi.org/10.1053/j.ajkd.2015.02.3
41">[More Information]</a>
Jun, M., James, M., Manns, B., Quinn, R.,
Ravani, P., Tonelli, M., Perkovic, V.,
Winkelmayer, W., Ma, Z., Hemmelgarn, B.
(2015). The association between kidney function
and major bleeding
in older adults with atrial fibrillation starting
warfarin treatment: population based
observational study. BMJ, 350, 1-9. <a
href="http://dx.doi.org/10.1136/bmj.h246">[Mor
e Information]</a>
Roberts, M., Pilmore, H., Ierino, F., Badve, S.,
Cass, A., Garg, A., Hawley, C., Isbel, N., Krum,
H., Pascoe, E., Perkovic, V., et al (2015). The
rationale and design of the Beta-blocker to
LOwer CArdiovascular Dialysis Events
(BLOCADE) Feasibility Study. Nephrology,
20(3), 140-147. <a
href="http://dx.doi.org/10.1111/nep.12362">[Mo
re Information]</a>
Thomas, M., Woodward, M., Neal, B., Li, Q.,
Pickering, R., Marre, M., Williams, B., Perkovic,
V., Cooper, M., Zoungas, S., Chalmers, J., Hillis,
G. (2015). The Relationship Between Levels of
Advanced Glycation End-Products and Their
Soluble Receptor and Adverse Outcomes in
Adults With Type 2 Diabetes. Diabetes Care,
38(10), 1891-1897. <a
href="http://dx.doi.org/10.2337/dc15-0925">[M
ore Information]</a>
Liyanage, T., Ninomiya, T., Jha, V., Neal, B.,
Patrice, H., Okpechi, I., Zhao, M., Lv, J., Garg,
A., Knight, J., Rodgers, A., Gallagher, M.,
Kotwal, S., Cass, A., Perkovic, V. (2015).
Worldwide access to treatment for end-stage
kidney disease: a systematic review. The Lancet,
385(9981), 1975-1982. <a
href="http://dx.doi.org/10.1016/S0140-6736(14)
61601-9">[More Information]</a>
2014
Publications for Vlado Perkovic
Ninomiya, T., Perkovic, V. (2014). Authors'
reply to Ladapo and Ogedegbe. BMJ, 348, 1-1.
<a
href="http://dx.doi.org/10.1136/bmj.g148">[Mor
e Information]</a>
Sundström, J., Arima, H., Woodward, M.,
Jackson, R., Karmali, K., Lloyd-Jones, D.,
Baigent, C., Emberson, J., Rahimi, K.,
MacMahon, S., Patel, A., Perkovic, V., Neal, B.,
et al (2014). Blood pressure-lowering treatment
based on cardiovascular risk: a meta-analysis of
individual patient data. The Lancet, 384(9943),
591-598. <a
href="http://dx.doi.org/10.1016/S0140-6736(14)
61212-5">[More Information]</a>
Pilmore, H., Dogra, G., Roberts, M., Lambers
Heerspink, H., Ninomiya, T., Huxley, R.,
Perkovic, V. (2014). Cardiovascular disease in
patients with chronic kidney disease.
Nephrology, 19(1), 3-10. <a
href="http://dx.doi.org/10.1111/nep.12148">[Mo
re Information]</a>
Wang, A., Ninomiya, T., Al-Kahwa, A.,
Perkovic, V., Gallagher, M., Hawley, C., Jardine,
M. (2014). Effect of Hemodiafiltration or
Hemofiltration Compared With Hemodialysis on
Mortality and Cardiovascular Disease in Chronic
Kidney Failure: A Systematic Review and
Meta-analysis of Randomized Trials. American
Journal of Kidney Diseases, 63(6), 968-978. <a
href="http://dx.doi.org/10.1053/j.ajkd.2014.01.4
35">[More Information]</a>
Bose, B., Badve, S., Hiremath, S., Boudville, N.,
Brown, F., Cass, A., de Zoysa, J., Fassett, R.,
Faull, R., Harris, D., Perkovic, V., Rangan, G., et
al (2014). Effects of uric acid-lowering therapy
on renal outcomes: a systematic review and
meta-analysis. Nephrology, Dialysis,
Transplantation, 29(2), 406-413. <a
href="http://dx.doi.org/10.1093/ndt/gft378">[Mo
re Information]</a>
Yamout, H., Perkovic, V., Davies, M., Woo, V.,
de Zeeuw, D., Mayer, C., Vijapurkar, U., Kline,
I., Usiskin, K., Meininger, G., et al (2014).
Efficacy and safety of canagliflozin in patients
with type 2 diabetes and stage 3 nephropathy.
American Journal of Nephrology, 40(1), 64-74.
<a
href="http://dx.doi.org/10.1159/000364909">[M
ore Information]</a>
Morrish, A., Hawley, C., Johnson, D., Badve, S.,
Perkovic, V., Reidlinger, D., Cass, A. (2014).
Establishing a clinical trials network in
nephrology: Experience of the Australasian
Kidney Trials Network. Kidney International,
85(1), 23-30. <a
href="http://dx.doi.org/10.1038/ki.2013.391">[
More Information]</a>
Zoungas, S., Chalmers, J., Neal, B., Billot, L., Li,
Q., Hirakawa, Y., Arima, H., Monaghan, H.,
Joshi, R., Colagiuri, S., Perkovic, V., Rodgers,
A., MacMahon, S., Patel, A., Woodward, M., et
al (2014). Follow-up of blood-pressure lowering
and glucose control in type 2 diabetes. The New
England Journal of Medicine, 371(15),
1392-1406. <a
href="http://dx.doi.org/10.1056/NEJMoa140796
3">[More Information]</a>
Palmer, S., Navaneethan, S., Craig, J., Perkovic,
V., Johnson, D., Nigwekar, S., Hegbrant, J.,
Strippoli, G. (2014). HMG CoA reductase
inhibitors (statins) for kidney transplant
recipients. Cochrane Database of Systematic
Reviews, 2014 (1), 1-57. <a
href="http://dx.doi.org/10.1002/14651858.CD00
5019.pub4">[More Information]</a>
Palmer, S., Navaneethan, S., Craig, J., Johnson,
D., Perkovic, V., Hegbrant, J., Strippoli, G.
(2014). HMG CoA reductase inhibitors (statins)
for people with chronic kidney disease not
requiring dialysis. Cochrane Database of
Systematic Reviews, 5, 1-136. <a
href="http://dx.doi.org/10.1002/14651858.CD00
7784.pub2">[More Information]</a>
Perkovic, V., Turnbull, F., Wilson, A. (2014). Is
it time for Medi-change? Medical Journal of
Australia, 200(10), 566-567. <a
href="http://dx.doi.org/10.5694/mja14.00427">[
More Information]</a>
Wang, A., Jardine, M., Perkovic, V. (2014).
Kidney Disease in Diabetes. In D. John
Betteridge, Stephen Nicholls (Eds.), Managing
Cardiovascular Complications in Diabetes, (pp.
58-86). Chichester: John Wiley & Sons.
Knight, J., Wong, M., Perkovic, V. (2014).
Optimal targets for blood pressure control in
chronic kidney disease: the debate continues.
Current Opinion In Nephrology And
Hypertension, 23(6), 541-546. <a
href="http://dx.doi.org/10.1097/MNH.00000000
00000060">[More Information]</a>
de Zeeuw, D., Coll, B., Andress, D., Brennan, J.,
Tang, H., Houser, M., Correa-Rotter, R., Kohan,
D., Lambers Heerspink, H., Makino, H.,
Perkovic, V., et al (2014). The endothelin
antagonist atrasentan lowers residual albuminuria
in patients with type 2 diabetic nephropathy.
Journal of the American Society of Nephrology,
25(5), 1083-1093. <a
href="http://dx.doi.org/10.1681/ASN.201308083
0">[More Information]</a>
Huxley, R., Perkovic, V. (2014). The modifiable
burden of worldwide mortality from
cardiovascular diseases. The Lancet Diabetes &
Endocrinology, 2(8), 604-606. <a
href="http://dx.doi.org/10.1016/S2213-8587(14)
Publications for Vlado Perkovic
70040-3">[More Information]</a>
Hillis, G., Welsh, P., Chalmers, J., Perkovic, V.,
Chow, C., Li, Q., Jun, M., Neal, B., Zoungas, S.,
Poulter, N., Woodward, M., et al (2014). The
relative and combined ability of high sensitivity
cardiac troponin T and N-terminal pro-B-type
Natriuretic Peptide to predict cardiovascular
events and death in patients with type 2 diabetes.
Diabetes Care, 37(1), 295-303. <a
href="http://dx.doi.org/10.2337/dc13-1165">[M
ore Information]</a>
2013
Sindone, A., Erlich, J., Perkovic, V., Suranyi,
M., Newman, H., Lee, C., Barin, E., Roger, S.
(2013). ACEIs for cardiovascular risk reduction:
Have we taken our eye off the ball? Australian
Family Physician, 42(9), 634-638. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=24024224">[More Information]</a>
Wang, A., Ivany, J., Perkovic, V., Gallagher, M.,
Jardine, M. (2013). Anticoagulant therapies for
the prevention of intravascular catheters
malfunction in patients undergoing
haemodialysis: systematic review and
meta-analysis of randomized, controlled trials.
Nephrology, Dialysis, Transplantation, 28(11),
2875-2888. <a
href="http://dx.doi.org/10.1093/ndt/gft406">[Mo
re Information]</a>
Palmer, S., Di Micco, L., Razavian, M., Craig, J.,
Perkovic, V., Pellegrini, F., Jardine, M., Webster,
A., Zoungas, S., Strippoli, G., et al (2013).
Antiplatelet agents for chronic kidney disease.
Cochrane Database of Systematic Reviews, 2013
(4), 1-136. <a
href="http://dx.doi.org/10.1002/14651858.CD00
8834.pub3">[More Information]</a>
Palmer, S., Di Micco, L., Razavian, M., Craig, J.,
Ravani, P., Perkovic, V., Tognoni, G., Graziano,
G., Jardine, M., Pellegrini, F., Webster, A.,
Strippoli, G., et al (2013). Antiplatelet Therapy
to Prevent Hemodialysis Vascular Access
Failure: Systematic Review and Meta-analysis.
American Journal of Kidney Diseases, 61(1),
112-122. <a
href="http://dx.doi.org/10.1053/j.ajkd.2012.08.0
31">[More Information]</a>
Ninomiya, T., Perkovic, V., Turnbull, F., Neal,
B., Barzi, F., Cass, A., Baigent, C., Chalmers, J.,
Li, N., Woodward, M., MacMahon, S. (2013).
Blood pressure lowering and major
cardiovascular events in people with and without
chronic kidney disease: meta-analysis of
randomised controlled trials. BMJ, 347(7929),
1-15. <a
href="http://dx.doi.org/10.1136/bmj.f5680">[Mo
re Information]</a>
Perkovic, V., Woodward, M., Zoungas, S.,
Chalmers, J. (2013). Caution advised in
interpreting nonsignificant results from
ADVANCE post hoc analysis. Kidney
International, 84(3), 622-622. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=23989363">[More Information]</a>
Wong, M., Perkovic, V., Woodward, M.,
Chalmers, J., Li, Q., Hillis, G., Azari, E., Jun,
M., Poulter, N., Hamet, P., Neal, B., Pollock, C.,
et al (2013). Circulating bone morphogenetic
protein-7 and transforming growth factor-(beta)1
are better predictors of renal end points in
patients with type 2 diabetes mellitus. Kidney
International, 83(2), 278-284. <a
href="http://dx.doi.org/10.1038/ki.2012.383">[
More Information]</a>
Wang, A., Ivany, J., Perkovic, V., Gallagher, M.,
Jardine, M. (2013). Corrigendum: Anticoagulant
therapies for the prevention of intravascular
catheters malfunction in patients undergoing
haemodialysis: systematic review and
meta-analysis of randomized, controlled trials.
Nephrology, Dialysis, Transplantation, 28,
3127-3127.
Hou, W., Lv, J., Perkovic, V., Yang, L., Zhao,
N., Jardine, M., Cass, A., Zhang, H., Wang, H.
(2013). Effect of statin therapy on cardiovascular
and renal outcomes in patients with chronic
kidney disease: a systematic review and
meta-analysis. European Heart Journal, 34(24),
1807-1817. <a
href="http://dx.doi.org/10.1093/eurheartj/eht065
">[More Information]</a>
Lv, J., Ehteshami, P., Sarnak, M., Tighiouart, H.,
Jun, M., Ninomiya, T., Foote, C., Rodgers, A.,
Zhang, H., Wang, H., Strippoli, G., Perkovic, V.
(2013). Effects of intensive blood pressure
lowering on the progression of chronic kidney
disease: a systematic review and meta-analysis.
CMAJ, 185(11), 949-957. <a
href="http://dx.doi.org/10.1503/cmaj.121468">[
More Information]</a>
Levin, A., Perkovic, V. (2013). Epidemiology:
Global Burden of Disease Study 2010:
implications for nephrology. Nature Reviews
Nephrology, 9(4), 195-197. <a
href="http://dx.doi.org/10.1038/nrneph.2013.38"
>[More Information]</a>
Perkovic, V., Neuen, B., Taylor, G., Demaio, A.
(2013). Global kidney disease. The Lancet,
382(9900), 1243.
Palmer, S., Navaneethan, S., Craig, J., Johnson,
D., Perkovic, V., Nigwekar, S., Hegbrant, J.,
Strippoli, G. (2013). HMG CoA reductase
inhibitors (statins) for dialysis patients. Cochrane
Database of Systematic Reviews, 2013 (9), 1-81.
Publications for Vlado Perkovic
<a
href="http://dx.doi.org/10.1002/14651858.CD00
4289.pub5">[More Information]</a>
MacMahon, S., Perkovic, V., Patel, A. (2013).
Industry-sponsored clinical trials in emerging
markets: time to review the terms of engagement.
JAMA, 310(9), 907-908. <a
href="http://dx.doi.org/10.1001/jama.2013.27691
3">[More Information]</a>
Perkovic, V., Heerspink, H., Chalmers, J.,
Woodward, M., Jun, M., Li, Q., MacMahon, S.,
Cooper, M., Hamet, P., Marre, M., Cass, A.,
Patel, A., Zoungas, S., et al (2013). Intensive
glucose control improves kidney outcomes in
patients with type 2 diabetes. Kidney
International, 83(3), 517-523. <a
href="http://dx.doi.org/10.1038/ki.2012.401">[
More Information]</a>
Badve, S., Beller, E., Cass, A., Francis, D.,
Hawley, C., Macdougall, I., Perkovic, V.,
Johnson, D. (2013). Interventions for
erythropoietin-resistant anaemia in dialysis
patients. Cochrane Database of Systematic
Reviews, 2013 (8), 1-37. <a
href="http://dx.doi.org/10.1002/14651858.CD00
6861.pub3">[More Information]</a>
Groop, P., Cooper, M., Perkovic, V., Emser, A.,
Woerle, H., von Eynatten, M. (2013). Linagliptin
lowers albuminuria on top of recommended
standard treatment in patients with type 2
diabetes and renal dysfunction. Diabetes Care,
36(11), 3460-3468. <a
href="http://dx.doi.org/10.2337/dc13-0323">[M
ore Information]</a>
Jardine, M., Liyanage, T., Buxton, E., Perkovic,
V. (2013). mTOR inhibition in
autosomal-dominant polycystic kidney disease
(ADPKD): the question remains open.
Nephrology, Dialysis, Transplantation, 28(2),
242-244. <a
href="http://dx.doi.org/10.1093/ndt/gfs519">[M
ore Information]</a>
Jun, M., Jardine, M., Gray, N., Masterson, R.,
Kerr, P., Agar, J., Hawley, C., van Eps, C., Cass,
A., Gallagher, M., Perkovic, V. (2013).
Outcomes of Extended-Hours Hemodialysis
Performed Predominantly at Home. American
Journal of Kidney Diseases, 61(2), 247-253. <a
href="http://dx.doi.org/10.1053/j.ajkd.2012.08.0
32">[More Information]</a>
Mooney, J., Ranasinghe, I., Chow, C., Perkovic,
V., Barzi, F., Zoungas, S., Holzmann, M.,
Welten, G., Biancari, F., Wu, V., Cass, A., Hillis,
G., et al (2013). Preoperative Estimates of
Glomerular Filtration Rate as Predictors of
Outcome after Surgery: A Systematic Review
and Meta-analysis. Anesthesiology, 118(4),
809-824. <a
href="http://dx.doi.org/10.1097/ALN.0b013e318
287b72c">[More Information]</a>
Neal, B., Perkovic, V., de Zeeuw, D., Mahaffey,
K., Fulcher, G., Stein, P., Desai, M., Shaw, W.,
Jiang, J., Vercruysse, F., et al (2013). Rationale,
design, and baseline characteristics of the
Canagliflozin Cardiovascular Assessment Study
(CANVAS)-A randomized placebo-controlled
trial. American Heart Journal, 166(2), 217-223.
<a
href="http://dx.doi.org/10.1016/j.ahj.2013.05.00
7">[More Information]</a>
Zhu, B., Wang, Y., Jardine, M., Jun, M., Lv, J.,
Cass, A., Liyanage, T., Cheng, H., Wang, Y.,
Perkovic, V. (2013). Tripterygium Preparations
for the Treatment of CKD: A Systematic Review
and Meta-analysis. American Journal of Kidney
Diseases, 62(3), 515-530. <a
href="http://dx.doi.org/10.1053/j.ajkd.2013.02.3
74">[More Information]</a>
2012
Wang, Y., Ivany, J., Perkovic, V., Gallagher, M.,
Jardine, M. (2012). Anticoagulants and
antiplatelet agents for preventing central venous
haemodialysis catheter malfunction in patients
with end-stage kidney disease. Cochrane
Database of Systematic Reviews, 2012 (2), 1-11.
<a
href="http://dx.doi.org/10.1002/14651858.CD00
9631">[More Information]</a>
Lv, J., Perkovic, V., Foote, C., Craig, M., Craig,
J., Strippoli, G. (2012). Antihypertensive agents
for preventing diabetic kidney disease (Review).
Cochrane Database of Systematic Reviews, (12),
1-90. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=23235603">[More Information]</a>
Jun, M., Venkataraman, V., Razavian, M.,
Cooper, B., Zoungas, S., Ninomiya, T., Webster,
A., Perkovic, V. (2012). Antioxidants for chronic
kidney disease (Review). Cochrane Database of
Systematic Reviews, 10, 1-61. <a
href="http://dx.doi.org/10.1002/14651858.CD00
8176.pub2">[More Information]</a>
Razavian, M., Heeley, E., Perkovic, V., Zoungas,
S., Weekes, A., Patel, A., Anderson, C.,
Chalmers, J., Cass, A. (2012). Cardiovascular
risk management in chronic kidney disease in
general practice (the AusHEART study).
Nephrology, Dialysis, Transplantation, 27(4),
1396-1402. <a
href="http://dx.doi.org/10.1093/ndt/gfr599">[Mo
re Information]</a>
Lv, J., Xu, D., Perkovic, V., Ma, X., Johnson, D.,
Woodward, M., Levin, A., Zhang, H., Wang, H.
(2012). Corticosteroid Therapy in IgA
Publications for Vlado Perkovic
Nephropathy. Journal of the American Society of
Nephrology, 23(6), 1108-1116. <a
href="http://dx.doi.org/10.1681/ASN.201111111
2">[More Information]</a>
Palmer, S., Di Micco, L., Razavian, M., Craig, J.,
Perkovic, V., Pellegrini, F., Copetti, M.,
Graziano, G., Tognoni, G., Jardine, M., Webster,
A., Strippoli, G., et al (2012). Effects of
Antiplatelet Therapy on Mortality and
Cardiovascular and Bleeding Outcomes in
Persons With Chronic Kidney Disease: A
Systematic Review and Meta-analysis. Annals of
Internal Medicine, 156(6), 445-459. <a
href="http://dx.doi.org/10.1059/0003-4819-1566-201203200-00007">[More Information]</a>
Jun, M., Zhu, B., Tonelli, M., Jardine, M., Patel,
A., Neal, B., Liyanage, T., Keech, A., Cass, A.,
Perkovic, V. (2012). Effects of Fibrates in
Kidney Disease: A Systematic Review and
Meta-Analysis. Journal of the American College
of Cardiology, 60(20), 2061-2071. <a
href="http://dx.doi.org/10.1016/j.jacc.2012.07.04
9">[More Information]</a>
Lv, J., Neal, B., Ehteshami, P., Ninomiya, T.,
Woodward, M., Rodgers, A., Wang, H.,
MacMahon, S., Turnbull, F., Hillis, G.,
Chalmers, J., Perkovic, V. (2012). Effects of
intensive blood pressure lowering on
cardiovascular and renal outcomes: a systematic
review and meta-analysis. PLoS Medicine, 9(8),
1-14. <a
href="http://dx.doi.org/10.1371/journal.pmed.10
01293">[More Information]</a>
Foote, C., Perkovic, V., Neal, B. (2012). Effects
of SGLT2 inhibitors on cardiovascular outcomes.
Diabetes and Vascular Disease Research, 9(2),
117-123. <a
href="http://dx.doi.org/10.1177/1479164112441
190">[More Information]</a>
Perkovic, V., Patil, V., Wei, L., Lv, J., Petersen,
M., Patel, A. (2012). Global Randomized Trials:
The Promise of India and China. Journal of Bone
and Joint Surgery: American Volume, 94(Suppl
1(E)), 92-96. <a
href="http://dx.doi.org/10.2106/JBJS.L.00274">[
More Information]</a>
Jun, M., Lo, C., Badve, S., Pilmore, H., White,
S., Hawley, C., Cass, A., Perkovic, V., Zoungas,
S. (2012). Glucose lowering therapies for chronic
kidney disease and kidney transplantation
(Protocol). Cochrane Database of Systematic
Reviews, 2012 (8), 1-13. <a
href="http://dx.doi.org/10.1002/14651858.CD00
9966">[More Information]</a>
Zhu, B., Jun, M., Jardine, M., Wang, Y.,
Perkovic, V. (2012). Haemodialysis duration,
frequency and intensity for end-stage kidney
disease (Protocol). Cochrane Database of
Systematic Reviews, 2012 (9), 1-10. <a
href="http://dx.doi.org/10.1002/14651858.CD01
0064">[More Information]</a>
Becker, G., Wheeler, D., de Zeeuw, D., Fujita,
T., Furth, S., Holdaas, H., Mendis, S., Oparil, S.,
Perkovic, V., Rodrigues, C., et al (2012).
KDIGO Clinical Practice Guideline for the
Management of Blood Pressure in Chronic
Kidney Disease. Kidney International
Supplements, 2(5), 337-414. <a
href="http://dx.doi.org/10.1038/kisup.2012.47">
[More Information]</a>
Kotwal, S., Jun, M., Sullivan, D., Perkovic, V.,
Neal, B. (2012). Omega 3 Fatty Acids and
Cardiovascular Outcomes: Systematic Review
and Meta-Analysis. Circulation. Cardiovascular
Quality and Outcomes, 5(6), 808-818. <a
href="http://dx.doi.org/10.1161/CIRCOUTCOM
ES.112.966168">[More Information]</a>
Toussaint, N., Pedagogos, E., Tan, S., Badve, S.,
Hawley, C., Perkovic, V., Elder, G. (2012).
Phosphate in early chronic kidney disease:
Associations with clinical outcomes and a target
to reduce cardiovascular risk. Nephrology, 17(5),
433-444. <a
href="http://dx.doi.org/10.1111/j.1440-1797.201
2.01618.x">[More Information]</a>
Jardine, M., Hata, J., Woodward, M., Perkovic,
V., Ninomiya, T., Arima, H., Zoungas, S., Cass,
A., Patel, A., Marre, M., Chalmers, J., et al
(2012). Prediction of Kidney-Related Outcomes
in Patients With Type 2 Diabetes. American
Journal of Kidney Diseases, 60(5), 770-778. <a
href="http://dx.doi.org/10.1053/j.ajkd.2012.04.0
25">[More Information]</a>
Hillis, G., Hata, J., Woodward, M., Perkovic, V.,
Arima, H., Chow, C., Zoungas, S., Patel, A.,
Poulter, N., Mancia, G., Chalmers, J., et al
(2012). Resting Heart Rate and the Risk of
Microvascular Complications in Patients With
Type 2 Diabetes Mellitus. Journal of the
American Heart Association, 1(5), 1-11. <a
href="http://dx.doi.org/10.1161/JAHA.112.0028
32">[More Information]</a>
Foote, C., Ninomiya, T., Gallagher, M.,
Perkovic, V., Cass, A., McDonald, S., Jardine,
M. (2012). Survival of elderly dialysis patients is
predicted by both patient and practice
characteristics. Nephrology, Dialysis,
Transplantation, 27, 3581-3587. <a
href="http://dx.doi.org/10.1093/ndt/gfs096">[M
ore Information]</a>
Jardine, M., Kang, A., Zoungas, S.,
Navaneethan, S., Ninomiya, T., Nigwekar, S.,
Gallagher, M., Cass, A., Strippoli, G., Perkovic,
V. (2012). The effect of folic acid based
homocysteine lowering on cardiovascular events
in people with kidney disease: systematic review
Publications for Vlado Perkovic
and meta-analysis. BMJ, 344(7863), 1-11. <a
href="http://dx.doi.org/10.1136/bmj.e3533">[Mo
re Information]</a>
Wong, G., Zoungas, S., Lo, S., Chalmers, J.,
Cass, A., Neal, B., Woodward, M., Perkovic, V.,
Glasziou, P., Williams, B., Howard, K.,
Chapman, J., Craig, J. (2012). The risk of cancer
in people with diabetes and chronic kidney
disease. Nephrology, Dialysis, Transplantation,
27(8), 3337-3344. <a
href="http://dx.doi.org/10.1093/ndt/gfs022">[M
ore Information]</a>
Perkovic, V., Neal, B. (2012). Trials in Kidney
Disease - Time to EVOLVE. The New England
Journal of Medicine, 367(26), 2541-2542. <a
href="http://dx.doi.org/10.1056/NEJMe1212368
">[More Information]</a>
2011
Maione, A., Navaneethan, S., Graziano, G.,
Mitchell, R., Johnson, D., Mann, J., Gao, P.,
Craig, J., Tognoni, G., Perkovic, V., Strippoli,
G., et al (2011). Angiotensin-converting enzyme
inhibitors, angiotensin receptor blockers and
combined therapy in patients with micro- and
macroalbuminuria and other cardiovascular risk
factors: a systematic review of randomized
controlled trials. Nephrology, Dialysis,
Transplantation, 26(9), 2827-2847. <a
href="http://dx.doi.org/10.1093/ndt/gfq792">[M
ore Information]</a>
Perkovic, V. (2011). Blood pressure lowering in
CKD. 4th European Meeting on Uraemia and
Cardiovascular Disease, Not-Known.
Lv, J., Perkovic, V. (2011). Blood pressure
management in diabetes: a path forward? Journal
of Hypertension, 29(7), 1283-1284. <a
href="http://dx.doi.org/10.1097/HJH.0b013e328
3491537">[More Information]</a>
Badve, S., Brown, F., Hawley, C., Johnson, D.,
Kanellis, J., Rangan, G., Perkovic, V. (2011).
Challenges of conducting a trial of
uric-acid-lowering therapy in CKD. Nature
Reviews Nephrology, 7(5), 295-300. <a
href="http://dx.doi.org/10.1038/nrneph.2010.186
">[More Information]</a>
Badve, S., Roberts, M., Hawley, C., Cass, A.,
Garg, A., Krum, H., Tonkin, A., Perkovic, V.
(2011). Effects of Beta-adrenergic antagonists in
patients with chronic kidney disease a systematic
review and meta-analysis. Journal of the
American College of Cardiology, 58(11),
1152-1161. <a
href="http://dx.doi.org/10.1016/j.jacc.2011.04.04
1">[More Information]</a>
Jun, M., Perkovic, V., Cass, A. (2011). Intensive
Glycemic Control and Renal Outcome.
Contributions to Nephrology, 170, 196-208. <a
href="http://dx.doi.org/10.1159/000325664">[M
ore Information]</a>
Komala, M., Pianta, T., Jardine, M., Webster, A.,
Perkovic, V. (2011). Interventions for preventing
intradialytic hypotension inhaemodialysis
patients (Protocol). Cochrane Database of
Systematic Reviews, (12), 1-12. <a
href="http://dx.doi.org/10.1002/14651858.CD00
9459.">[More Information]</a>
Heerspink, H., Perkovic, V., de Zeeuw, D.
(2011). Is doubling of serum creatinine a valid
clinical 'hard' endpoint in clinical nephrology
trials? Nephron Clinical Practice, 119(3),
c195-c199. <a
href="http://dx.doi.org/10.1159/000327614">[M
ore Information]</a>
Huxley, R., Barzi, F., Lam, T., Czernichow, S.,
Fang, X., Welborn, T., Shaw, J., Ueshima, H.,
Zimmet, P., Jee, S., Caterson, I., Perkovic, V.,
Woodward, M., et al (2011). Isolated Low
Levels of High-Density Lipoprotein Cholesterol
Are Associated With an Increased Risk of
Coronary Heart Disease: An Individual
Participant Data Meta-Analysis of 23 Studies in
the Asia-Pacific Region. Circulation, 124(19),
2056-2064. <a
href="http://dx.doi.org/10.1161/CIRCULATION
AHA.111.028373">[More Information]</a>
Perkovic, V., Jun, M., Lv, J., Jardine, M. (2011).
Managing cardiovascular risk in people with
chronic kidney disease: a review of the evidence
from randomized controlled trials. Therapeutic
Advances in Chronic Diseases, 2(4), 265-278. <a
href="http://dx.doi.org/10.1177/2040622311401
77">[More Information]</a>
Perkovic, V. (2011). Overview of clinical trials
in acute Kidney Injury. World Congress of
Nephrology 2011, Not-Known: International
Society of Nephrology.
Perkovic, V., Huxley, R. (2011). Prognostic
value of CRP in stable coronary artery disease
unclear due to a variety of biases in existing
studies, therefore no clinical practice
recommendations can be made. Advances in
Colloid and Interface Science, 167(1-2), 94-103.
<a
href="http://dx.doi.org/10.1136/ebm1143">[Mor
e Information]</a>
Zentner, D., Hunt, D., Chan, W., Barzi, F.,
Grigg, L., Perkovic, V. (2011). Prospective
evaluation of aortic stenosis in end-stage kidney
disease: a more fulminant process? Nephrology,
Dialysis, Transplantation, 26(5), 1651-1655. <a
href="http://dx.doi.org/10.1093/ndt/gfq596">[M
ore Information]</a>
Czernichow, S., Zanchetti, A., Turnbull, F.,
Barzi, F., Ninomiya, T., Kengne, A., Heerspink,
Publications for Vlado Perkovic
H., Perkovic, V., Huxley, R., Arima, H., Patel,
A., Chalmers, J., Woodward, M., MacMahon, S.,
Neal, B. (2011). The effects of blood pressure
reduction and of different blood
pressure-lowering regimens on major
cardiovascular events according to baseline
blood pressure: meta-analysis of randomized
trials. Journal of Hypertension, 29(1), 4-16. <a
href="http://dx.doi.org/10.1097/HJH.0b013e328
34000be">[More Information]</a>
Perkovic, V. (2011). Thrice weekly
Hemodialysis is obsolete and should not be
offered as standard treatment for ESRD. World
Congress of Nephrology 2011, Not-Known:
International Society of Nephrology.
2010
Tsukamoto, Y., Jha, V., Becker, G., Chen, H.,
Perkovic, V., Prodjosudjadi, W., Tungsanga, K.,
Wang, H., Morad, Z. (2010). A challenge to
chronic kidney disease in Asia: The report of the
second Asian Forum of Chronic Kidney Disease
Initiative. Nephrology, 15(2), 248-252. <a
href="http://dx.doi.org/10.1111/j.1440-1797.200
9.01269.x">[More Information]</a>
Razavian, M., Di Micco, L., Palmer, S., Craig, J.,
Perkovic, V., Zoungas, S., Webster, A., Jardine,
M., Strippoli, G. (2010). Antiplatelet agents for
chronic kidney disease (Protocol). Cochrane
Database of Systematic Reviews, 2010 (11),
1-16. <a
href="http://dx.doi.org/10.1002/14651858.CD00
8834">[More Information]</a>
Jardine, M., Ninomiya, T., Perkovic, V., Cass,
A., Turnbull, F., Gallagher, M., Zoungas, S.,
Heerspink, H., Chalmers, J., Zanchetti, A.
(2010). Aspirin is beneficial in hypertensive
patients with chronic kidney disease a post-hoc
subgroup analysis of a randomized controlled
trial. Journal of the American College of
Cardiology, 56(12), 956-965. <a
href="http://dx.doi.org/10.1016/j.jacc.2010.02.06
8">[More Information]</a>
Lambers Heerspink, H., Ninomiya, T., Perkovic,
V., Woodward, M., Zoungas, S., Cass, A.,
Cooper, M., Grobbee, D., Mancia, G.,
Mogensen, C., Neal, B., Chalmers, J. (2010).
Effects of a fixed combination of perindopril and
indapamide in patients with type 2 diabetes and
chronic kidney disease. European Heart Journal,
31(23), 2888-2896. <a
href="http://dx.doi.org/10.1093/eurheartj/ehq139
">[More Information]</a>
Perkovic, V., Jun, M., Neal, B. (2010). Effects of
fibrates on cardiovascular outcomes - Authors'
reply. The Lancet, 376(9746), 1051-1052. <a
href="http://dx.doi.org/10.1016/S0140-6736(10)
61482-1">[More Information]</a>
Neal, B., Jun, M., Foote, C., Lv, J., Patel, A.,
Nicholls, S., Grobbee, D., Cass, A., Chalmers, J.,
Perkovic, V. (2010). Effects of fibrates on
cardiovascular outcomes: a systematic review
and meta-analysis. The Lancet, 375(9729),
1875-1884. <a
href="http://dx.doi.org/10.1016/S0140-6736(10)
60656-3">[More Information]</a>
Ninomiya, T., Zoungas, S., Neal, B., Woodward,
M., Patel, A., Perkovic, V., Cass, A., Cooper, M.,
Grobbee, D., Hamet, P., Rodgers, A.,
MacMahon, S., Chalmers, J., et al (2010).
Efficacy and safety of routine blood pressure
lowering in older patients with diabetes: results
from the ADVANCE trial. Journal of
Hypertension, 28(6), 1141-1149. <a
href="http://dx.doi.org/10.1097/HJH.0b013e328
338a89c">[More Information]</a>
Perkovic, V., Cass, A. (2010). Glomerular
filtration rate and the risk of stroke. BMJ
(online), 341, c4390. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=20884697">[More Information]</a>
Jun, M., Zoungas, S., Perkovic, V., Webster, A.
(2010). How to read a report of a randomized
controlled trial. Nephrology, 15(2), 153-157. <a
href="http://dx.doi.org/10.1111/j.1440-1797.200
9.01275.x">[More Information]</a>
Jun, M., Lambers Heerspink, H., Ninomiya, T.,
Gallagher, M., Bellomo, R., Myburgh, J., Finfer,
S., Palevsky, P., Kellum, J., Perkovic, V., Cass,
A. (2010). Intensities of Renal Replacement
Therapy in Acute Kidney Injury: A Systematic
Review and Meta-Analysis. Clinical Journal of
the American Society of Nephrology, 5(6),
956-963. <a
href="http://dx.doi.org/10.2215/CJN.09111209"
>[More Information]</a>
Badve, S., Beller, E., Cass, A., Francis, D.,
Hawley, C., Macdougall, I., Perkovic, V.,
Johnson, D. (2010). Interventions for
erythropoietin-resistant anaemia in dialysis
patients (Protocol). Cochrane Database of
Systematic Reviews, 2010 (1), 1-10. <a
href="http://dx.doi.org/10.1002/14651858.CD00
6861.pub2">[More Information]</a>
Gallagher, M., Kelly, P., Jardine, M., Perkovic,
V., Cass, A., Craig, J., Eris, J., Webster, A.
(2010). Long-Term Cancer Risk of
Immunosuppressive Regimens after Kidney
Transplantation. Journal of the American Society
of Nephrology, 21(5), 852-858. <a
href="http://dx.doi.org/10.1681/ASN.200910104
3">[More Information]</a>
Palmer, S., Navaneethan, S., Craig, J., Johnson,
D., Tonelli, M., Garg, A., Pellegrini, F., Ravani,
P., Jardine, M., Perkovic, V., Strippoli, G., et al
Publications for Vlado Perkovic
(2010). Meta-analysis:
Erythropoiesis-Stimulating Agents in Patients
With Chronic Kidney Disease. Annals of Internal
Medicine, 153(1), 23-34. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=20439566">[More Information]</a>
systematic review with meta-analysis. Archives
of Internal Medicine, 169(22), 2053-2063. <a
href="http://dx.doi.org/10.1001/archinternmed.2
009.439">[More Information]</a>
Perkovic, V. (2010). Optimal Blood Pressure
Target and Agents in Hemodialysis Patients?
42nd Annual Meeting of the Canadian Society of
Nephrology, Not-Known.
Gallagher, M., Jardine, M., Perkovic, V., Cass,
A., McDonald, S., Petrie, J., Eris, J. (2009).
Cyclosporine withdrawal improves long-term
graft survival in renal transplantation.
Transplantation, 87(12), 1877-1883. <a
href="http://dx.doi.org/10.1097/TP.0b013e3181a
76823">[More Information]</a>
Chalmers, J., Cooper, M., Grobbee, R., Hamet,
P., Kengne, A., MacMahon, S., Marre, M.,
Mogensen, C., Neal, B., Patel, A., et al (2010).
Protection against cardiovascular and renal
disease in type 2 diabetes: ADVANCEs in the
control of blood pressure Peterax and Diamicron
MR. In J Chalmers (Eds.), Action in Diabetes
and Vascular Disease: Preterax and Diamicron
Mr Controlled Evaluation. France: Wolters
Kluwer Health France.
Lambers Heerspink, H., Ninomiya, T., Zoungas,
S., de Zeeuw, D., Grobbee, D., Jardine, M.,
Gallagher, M., Roberts, M., Cass, A., Neal, B.,
Perkovic, V. (2009). Effect of lowering blood
pressure on cardiovascular events and mortality
in patients on dialysis: a systematic review and
meta-analysis of randomised controlled trials.
The Lancet, 373(9668), 1009-1015. <a
href="http://dx.doi.org/10.1016/S0140-6736(09)
60212-9">[More Information]</a>
2009
Hu, J., Jiang, X., Li, N., Yu, X., Perkovic, V.,
Chen, B., Zhao, L., Neal, B., Wu, Y. (2009).
Effects of salt substitute on pulse wave analysis
among individuals at high cardiovascular risk in
rural China: a randomized controlled trial.
Hypertension Research, 32(4), 282-288. <a
href="http://dx.doi.org/10.1038/hr.2009.7">[Mor
e Information]</a>
Ninomiya, T., Perkovic, V., de Galan, B.,
Zoungas, S., Pillai, A., Jardine, M., Patel, A.,
Cass, A., Neal, B., Poulter, N., Woodward, M.,
MacMahon, S., Chalmers, J., et al (2009).
Albuminuria and Kidney Function Independently
Predict Cardiovascular and Renal Outcomes in
Diabetes. Journal of the American Society of
Nephrology, 20(8), 1813-1821. <a
href="http://dx.doi.org/10.1681/ASN.200812127
0">[More Information]</a>
Perkovic, V., Venkataraman, V., Cooper, B.,
Zoungas, S., Webster, A. (2009). Antioxidants
for chronic kidney disease (Protocol). Cochrane
Database of Systematic Reviews, 2009 (4), 1-12.
<a
href="http://dx.doi.org/10.1002/14651858.CD00
8176">[More Information]</a>
O'Seaghdha, C., Perkovic, V., Lam, T., McGinn,
S., Barzi, F., Gu, D., Cass, A., Suh, I., Muntner,
P., Giles, G., Woodward, M., Huxley, R., et al
(2009). Blood Pressure Is a Major Risk Factor
for Renal Death. An Analysis of 560 352
Participants From the Asia-Pacific Region.
Hypertension, 54(3), 509-515. <a
href="http://dx.doi.org/10.1161/HYPERTENSIO
NAHA.108.128413">[More Information]</a>
Perkovic, V., Heerspink, H., Ninomiya, T., Cass,
A., Neal, B. (2009). Blood pressure lowering in
dialysis patients - look before we leap. The
Lancet, 373, 1945-1946.
Huxley, R., Lee, C., Barzi, F., Timmermeister,
L., Czernichow, S., Perkovic, V., Grobbee, D.,
Batty, G., Woodward, M. (2009). Coffee,
decaffeinated coffee, and tea consumption in
relation to incident type 2 diabetes mellitus: A
Navaneethan, S., Nigwekar, S., Perkovic, V.,
Johnson, D., Craig, J., Strippoli, G. (2009). HMG
CoA reductase inhibitors (statins) for dialysis
patients (Review). Cochrane Database of
Systematic Reviews, (3), 1-39. <a
href="http://dx.doi.org/10.1002/14651858.CD00
4289.pub4">[More Information]</a>
Navaneethan, S., Perkovic, V., Johnson, D.,
Nigwekar, S., Craig, J., Strippoli, G. (2009).
HMG CoA reductase inhibitors (statins) for
kidney transplant recipients. Cochrane Database
of Systematic Reviews, (2), 1-30. <a
href="http://dx.doi.org/10.1002/14651858.CD00
5019.pub3">[More Information]</a>
Navaneethan, S., Pansini, F., Perkovic, V.,
Manno, C., Pellegrini, F., Johnson, D., Craig, J.,
Strippoli, G. (2009). HMG CoA reductase
inhibitors (statins) for people with chronic
kidney disease not requiring dialysis. Cochrane
Database of Systematic Reviews, (2), 1-48. <a
href="http://dx.doi.org/10.1002/14651858.CD00
7784">[More Information]</a>
Huxley, R., Clifton, P., Perkovic, V., Woodward,
M., Neal, B. (2009). How many Australian
deaths from heart disease and stroke could be
avoided by a small reduction in population
cholesterol levels? Nutrition and Dietetics, 66(3),
158-163. <a
href="http://dx.doi.org/10.1111/j.1747-0080.200
Publications for Vlado Perkovic
9.01360.x">[More Information]</a>
Nigwekar, S., Cass, A., Gallagher, M., Jardine,
M., Kang, A., Kulshrestha, S., Navaneethan, S.,
Perkovic, V., Strippoli, G., Zoungas, S. (2009).
Interventions for lowering plasma homocysteine
levels in dialysis patients. Cochrane Database of
Systematic Reviews, 2, 1-12. <a
href="http://dx.doi.org/10.1002/14651858.CD00
4683.pub3">[More Information]</a>
Kang, A., Nigwekar, S., Perkovic, V.,
Kulshrestha, S., Zoungas, S., Navaneethan, S.,
Cass, A., Gallagher, M., Ninomiya, T., Strippoli,
G., et al (2009). Interventions for lowering
plasma homocysteine levels in kidney transplant
recipients [Protocol]. Cochrane Database of
Systematic Reviews, (3), 1-12. <a
href="http://dx.doi.org/10.1002/14651858.CD00
7910">[More Information]</a>
White, S., Perkovic, V., Cass, A., Chang, C.,
Poulter, N., Spector, T., Haysom, L., Craig, J., Al
Salmi, I., Chadban, S., Huxley, R. (2009). Is
Low Birth Weight an Antecedent of CKD in
Later Life? A Systematic Review of
Observational Studies. American Journal of
Kidney Diseases, 54(2), 248-261. <a
href="http://dx.doi.org/10.1053/j.ajkd.2008.12.0
42">[More Information]</a>
Perkovic, V., Jardine, M., Gallagher, M., Cass,
A. (2009). Lipid lowering in chronic kidney
disease. In A.M. Tonkin (Eds.), Therapeutic
Strategies in Lipid Disorders, (pp. 135-142).
United Kingdom: Clinical Publishing, Oxford.
de Galan, B., Perkovic, V., Ninomiya, T., Pillai,
A., Patel, A., Cass, A., Neal, B., Poulter, N.,
Harrap, S., Mogensen, C., Woodward, M.,
MacMahon, S., Chalmers, J., et al (2009).
Lowering Blood Pressure Reduces Renal Events
in
Type 2 Diabetes. Journal of the American
Society of Nephrology, 20(4), 883-892. <a
href="http://dx.doi.org/10.1681/ASN.200807066
7">[More Information]</a>
Ninomiya, T., Perkovic, V., Verdon, C., Barzi,
F., Cass, A., Gallagher, M., Jardine, M.,
Anderson, C., Chalmers, J., Craig, J., Huxley, R.
(2009). Proteinuria and Stroke: A Meta-analysis
of Cohort Studies. American Journal of Kidney
Diseases, 53(3), 417-425. <a
href="http://dx.doi.org/10.1053/j.ajkd.2008.08.0
32">[More Information]</a>
Lambers Heerspink, H., Perkovic, V., de Zeeuw,
D. (2009). Renal and cardio-protective effects of
direct renin inhibition: a systematic literature
review. Journal of Hypertension, 27(12),
2321-2331. <a
href="http://dx.doi.org/10.1097/HJH.0b013e328
3310f92">[More Information]</a>
Perkovic, V., Ninomiya, T., MacMahon, S.,
Chalmers, J. (2009). Renal and microalbuminuria
data from ADVANCE. In Bernard I. Levy,
Harry A.J. Struijker-Boudier (Eds.), Role of
Macro and Microcirculation in Target Organ
Damage in Diabetes and Hypertension, (pp.
121-132). West Sussex: Wiley-Blackwell
Publishing.
Joshi, R., de Galan, B., Chalmers, J., Perkovic,
V., Patel, A. (2009). Routine blood pressure
lowering and intense glucose control in patients
with type 2 diabetes: results from the
ADVANCE trial. Expert Review of
Endocrinology & Metabolism, 4(2), 111-118.
Zoungas, S., Ninomiya, T., Huxley, R., Cass, A.,
Jardine, M., Gallagher, M., Patel, A.,
Vasheghani-Farahani, A., Sadigh, G., Perkovic,
V. (2009). Systematic review: sodium
bicarbonate treatment regimens for the
prevention of contrast-induced nephropathy.
Annals of Internal Medicine, 151(9), 631-638. <a
href="http://dx.doi.org/10.1059/0003-4819-1519-200911030-00008">[More Information]</a>
2008
Perkovic, V. (2008). Anaemia management and
EBM: What have we learned? Australian
Clinical Nephrology Symposium 2008,
Not-Known.
Craig, J., Perkovic, V., Chadban, S., Cass, A.,
McDonald, S., Salkeld, G., Howard, K., White,
S. (2008). Cost effectiveness of screening for the
early diagnosis and treatment of risk factors for
chronic kidney disease: a Markov Monte Carlo
microsimulation using marck-E (model for the
assessment of risk factors for chronic kidney
disease - economics). 42nd Australia and New
Zealand Society of Nephrology Annual Scientific
Conference (2006), United States of America:
Wiley-Blackwell Publishing.
Perkovic, V. (2008). Diabetes, Kidney Disease
and Cardiovascular disease workshop.
AstraZeneca Cardiovascular Specialist
Symposium 2008, Not-Known.
Turnbull, F., Woodward, M., Neal, B., Barzi, F.,
Ninomiya, T., Chalmers, J., Perkovic, V., Li, N.,
MacMahon, S. (2008). Do men and women
respond differently to blood pressure-lowering
treatment? Results of prospectively designed
overviews of randomized trials. European Heart
Journal, 29(21), 2669-2680. <a
href="http://dx.doi.org/10.1093/eurheartj/ehn427
">[More Information]</a>
Turnbull, F., Neal, B., Ninomiya, T., Algert, C.,
Arima, H., Barzi, F., Bulpitt, C., Chalmers, J.,
Fagard, R., Gleason, A., Heritier, S., Perkovic,
V., Woodward, M., MacMahon, S., et al (2008).
Effects of different regimens to lower blood
Publications for Vlado Perkovic
pressure on major cardiovascular events in older
and younger adults: meta-analysis of randomised
trials. BMJ: British Medical Journal, 336(6753),
1121-1123. <a
href="http://dx.doi.org/10.1136/bmj.39548.7383
68.BE">[More Information]</a>
Strippoli, G., Navaneethan, S., Perkovic, V.,
Pellegrini, F., Nicolucci, A., Johnson, D., Craig,
J. (2008). Effects of statins in patients with
chronic kidney disease: meta-analysis and
meta-regression of randomised controlled trials.
BMJ: British Medical Journal, 336(7645), 1-14.
<a
href="http://dx.doi.org/10.1136/bmj.39472.5809
84.AE">[More Information]</a>
Perkovic, V., Cass, A., Patel, A.,
Suriyawongpaisal, P., Barzi, F., Chadban, S.,
MacMahon, S., Neal, B. (2008). High prevalence
of chronic kidney disease in Thailand. Kidney
International, 73(4), 473-479. <a
href="http://dx.doi.org/10.1038/sj.ki.5002701">[
More Information]</a>
Patel, A., MacMahon, S., Chalmers, J., Neal, B.,
Billot, L., Woodward, M., Marre, M., Cooper,
M., Glasziou, P., Grobbee, D., Joshi, R., et al
(2008). Intensive blood glucose control and
vascular outcomes in patients with type 2
diabetes. New England Journal of Medicine,
358(24), 2560-2572. <a
href="http://dx.doi.org/10.1056/NEJMoa080298
7">[More Information]</a>
Meeting of the Asian forum of CDK Initiative,
Not-Known.
Perkovic, V., Verdon, C., Ninomiya, T., Barzi,
F., Cass, A., Patel, A., Jardine, M., Gallagher,
M., Turnbull, F., Chalmers, J., Craig, J., Huxley,
R. (2008). The relationship between proteinuria
and coronary risk: a systematic review and
meta-analysis. PLoS Medicine, 5(10),
1486-1495. <a
href="http://dx.doi.org/10.1371/journal.pmed.00
50207">[More Information]</a>
2007
Perkovic, V., Ninomiya, T., Arima, H., Jardine,
M., Cass, A., Neal, B., MacMahon, S., Chalmers,
J. (2007). Chronic Kidney Disease,
Cardiovascular Events, and The Effects Of
Perindopril-Based Blood Pressure Lowering:
Data From The PROGRESS Study. Journal of
the American Society of Nephrology, 18(10),
2766-2772. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17804673">[More Information]</a>
Chalmers, J., Colagiuri, S., Grobbee, R., Hamet,
P., Kengne, A., MacMahon, S., Mogensen, C.,
Neal, B., Patel, A., Perkovic, V., et al (2007).
New approaches for the prevention of vascular
disease in type 2 diabetes: benefits of blood
pressure lowering with the fixed combination of
perindopril and indapamide. France: Wolters
Kluwer Health Pharma Solutions.
Ninomiya, T., Perkovic, V., Gallagher, M.,
Jardine, M., Cass, A., Arima, H., Anderson, C.,
Neal, B., Woodward, M., Omae, T., MacMahon,
S., Chalmers, J. (2008). Lower blood pressure
and risk of recurrent stroke in patients with
chronic kidney disease: PROGRESS trial.
Kidney International, 73(8), 963-970. <a
href="http://dx.doi.org/10.1038/ki.2008.5">[Mor
e Information]</a>
Chalmers, J., Kengne, A., Joshi, R., Perkovic, V.,
Patel, A. (2007). New insights from ADVANCE.
Journal of Hypertension, 25(Suppl. 1), S23-S30.
<a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17579315">[More Information]</a>
Chalmers, J., Colagiuri, S., Cooper, M., Grobbee,
R., Hamet, P., Kengne, A., MacMahon, S.,
Marre, M., Mogensen, C., Neal, B., Patel, A.,
Perkovic, V., et al (2008). Prevention of vascular
outcomes in type 2 diabetes: benefits of intensive
blood pressure and blood glucose control with
Preterax and Diamicron MR. France: Wolters
Kluwer Health France.
Chalmers, J., Perkovic, V., Joshi, R., Patel, A.
(2006). ADVANCE: breaking new ground in
type 2 diabetes. Journal of Hypertension,
24(Supplement 5), S22-S28. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16936533">[More Information]</a>
White, S., McGeechan, K., Jones, M., Cass, A.,
Chadban, S., Polkinghorne, K., Perkovic, V.,
Roderick, P. (2008). Socioeconomic
Disadvantage and Kidney Disease in the United
States, Australia, and Thailand. American
Journal of Public Health, 98(7), 1306-1313. <a
href="http://dx.doi.org/10.2105/AJPH.2007.1160
20">[More Information]</a>
Perkovic, V. (2008). Specific Consideration in
etiology and risk factor of ESKD in Asia. 2nd
2006
Perkovic, V., Joshi, R., Patel, A., Bompoint, S.,
Chalmers, J., Neal, B., MacMahon, S., Glasziou,
P., Woodward, M., Cooper, M., et al (2006).
ADVANCE: Lessons from the run-in phase of a
large study in type 2 diabetes. Blood Pressure,
15(6), 340-346. <a
href="http://dx.doi.org/10.1080/0803705060106
6074">[More Information]</a>
Howard, K., Salkeld, G., White, S., Chadban, S.,
Craig, J., Cass, A., McDonald, S., Perkovic, V.
(2006). Cost effectiveness of screening for the
Publications for Vlado Perkovic
early diagnosis and treatment of risk factors for
chronic kidney disease: A Markov Monte Carlo
microsimulation using Marck-E. 42nd Annual
Scientific Meeting of the Australian and New
Zealand Society of Nephrology.
Gallagher, M., Perkovic, V., Chalmers, J. (2006).
Diuretics: A modern day treatment option?
(Review Article). Nephrology, 11(5), 419-427.
<a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17014556">[More Information]</a>
Howard, K., Salkeld, G., White, S., Chadban, S.,
Craig, J., McDonald, S., Perkovic, V., Cass, A.
(2006). The cost-effectiveness of early detection
and intervention to prevent the progression of
Chronic Kidney Disease in Australia.
Howard, K., Salkeld, G., White, S., Chadban, S.,
Craig, J., McDonald, S., Perkovic, V., Cass, A.
(2006). The Cost-Effectiveness of Early
Detection and Intervention to Prevent the
Progression of Chronic Kidney Disease in
Australia.
2005
Kerr, P., Perkovic, V., Petrie, J., Agar, J.,
Disney, A. (2005). Dose of haemodialysis.
Nephrology, 10, S61-3. <a
href="http://dx.doi.org/10.1111/j.1440-1797.200
5.00464_1.x">[More Information]</a>
2003
Perkovic, V., Hewitson, T., Kelynack, K.,
Martic, M., Tait, M., Becker, G. (2003).
Parathyroid hormone has a prosclerotic effect on
vascular smooth muscle cells. Kidney and Blood
Pressure Research, 26(1), 27-33. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=12697974">[More Information]</a>